Copay caps on prescription drug costs could slow the growth of retirees' expected healthcare costs, a report from Fidelity found.
The Latest
The way North Carolina's Medicaid expansion is financed could incentivize hospitals to increase prices, experts wrote in an article published June 21 in Health Affairs.
Blue Cross and Blue Shield of Minnesota said access to peer support specialists will be a covered benefit for fully insured commercial plan members starting in 2024.
From proposed price transparency requirements under Medicaid to a new No Surprises Act website, these are 13 CMS moves reported by Becker's since April 1:
From major purchases by CVS Health to UnitedHealth Group's continued growth in the care delivery space, these are eight merger and acquisition deals within the health insurance industry that have closed since Jan. 1:
Mark Cuban Cost Plus Drug Co. is most known for selling cheap prescription drugs directly to consumers through the mail, but those cheap prices have been turned into a benefits solution for health plans.
Administrative costs for Blue Cross Blue Shield plans rose in 2022, according to an analysis from Sherlock Company.
Indiana Medicaid Director Allison Taylor is resigning later this summer after six years in the role, the Indiana Capital Chronicle reported June 20.
Georgia's Medicaid work requirement program is set to take effect July 1, and it could serve as a model for other states, Politico reported June 20.
Novo Nordisk, which manufactures Ozempic and Wegovy, has hired a lobbying firm to convince Congress to allow Medicare to cover the drugs for weight loss, Politico reported June 16.